[1]
H. A. Afiezan, M. Gea, R. G. Pakpahan, and K. Erwin, “DETERMINANTS OF INVESTMENT OPPORTUNITIES IN PHARMACEUTICAL COMPANIES REGISTERED ON THE IDX DURING THE COVID-19 PANDEMIC”, jit, vol. 17, no. 3, pp. 535–543, Jul. 2023.